pentadecapeptide arginate vs bpc-157 PDA IS REPLACING MY FAVORITE PEPTIDE BPC-157. Well the FDA screwed up several peptides for a lot of us BUT… We have just gotten our hands on an almost identical peptide called pentadecapeptide arginate vs bpc-157 Therapeutic

Research Benefits Compared Where BPC-157 Has Stronger Evidence Gut healing BPC-157 was literally derived from gastric juice

Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers Glc secretion, both in a glucose-dependent manner

B12 injections are a lifeline for those with absorption issues or heightened needs

They are running an uncontrolled experiment on their own tissue

While semaglutide pharmacokinetics are not significantly altered in patients with hepatic impairment, the medication has not been extensively studied in patients with severe hepatic dysfunction

Very high doses may occasionally cause hypokalaemia (low potassium), particularly in patients with severe megaloblastic anaemia when treatment is initiated, necessitating monitoring in hospital settings